Name change to Kyntra Bio reflects the newly sharpened focus of the Company on novel therapies with potential for outsized impact in oncology and rare disease Kyntra Bio will begin trading on Nasdaq ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results